Clinical Trials

Cytokine Clinical Trials

By Marta Catalfamo Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) Identifier: NCT05080790  Contact: Daniel Pink, Dr.              033631 73527   Contact: Melanie Prause              069 7601 4211 Sponsors and Collaborators Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest EUSA Pharma, Inc. [READ MORE]